Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

Call for Abstracts - Deadline July 10, 2015

Read Full Story

Call for Abstracts - SNO Annual Scientific Meeting

Submission deadline: June 15, 2015

Read Full Story

SNO MOURNS THE LOSS OF ANDREW PARSA

SNO is saddened to learn of the passing of respected Society leader

Read Full Story
View All News

June
08

16th Annual Drug Discovery Summit 2015

Read Full Story

June
26

North American Gamma Knife Consortium Meeting

Read Full Story

September
17

Asian Society for Neuro-Oncology Annual Meeting (ASNO 2015)

Read Full Story

Neuro-Oncology Impact Factor Rises

The Society for Neuro-Oncology is pleased to announce that the impact factor for Neuro-Oncology has risen to 6.180, putting the journal among the top ten titles in Clinical Neurology by the Science Citation Index.

This new, higher ranking reinforces Neuro-Oncology’s position as the leading journal in the field.

With a wealth of peer-reviewed articles and reviews, topical symposia, abstracts of annual meetings, and society news from around the world, the journal continues its mission to provide superior and rapid publication of information in all areas of neuro-oncology.

The three recent most highly cited papers are free to read via the below links.

 

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

Authors: de Groot, John F.; Fuller, Gregory; Kumar, Ashok J.; et al.

 

A multigene predictor of outcome in glioblastoma

Authors: Colman, Howard; Zhang, Li; Sulman, Erik P.; et al.

 

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

Authors: Raizer, Jeffrey J.; Abrey, Lauren E.; Lassman, Andrew B.; et al.

 

For more information

http://neuro-oncology.oxfordjournals.org/